Definition: A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. The cause is unknown. Median survival times of 10-15 years are commonly reported. (WHO, 2008)
Synonyms (terms occurring on more labels are shown first): essential thrombocythemia, essential thrombocythaemia
More information: PubMed search and possibly Wikipedia
Drugs with this side effect |
Drugs with this indication |